Pharvaris N.V.

The momentum for this stock is not very good. Pharvaris N.V. is a mediocre stock to choose.

News

Pharvaris (NASDAQ:PHVS) Price Target Raised to $42.00

Ticker Report Pharvaris (NASDAQ:PHVS - Free Report) had its target price lifted by Oppenheimer from $38.00 to $42.00 in a report released on Friday morning, Benzinga reports. They currently have an outperform...\n more…

Buy Rating on Pharvaris: Promising Results and Strategic Market Position for HAE Treatment

TipRanks Financial Blog Leerink Partners analyst Joseph Schwartz has reiterated their bullish stance on PHVS stock, giving a Buy rating on September 6. Joseph Schwartz has...\n more…

Pharvaris (NASDAQ:PHVS) Shares Gap Up Following Analyst Upgrade

Ticker Report Pharvaris (NASDAQ:PHVS - Get Free Report) shares gapped up prior to trading on Friday after Oppenheimer raised their price target on the stock from $38.00 to $42.00. The stock had previously closed...\n more…

Pharvaris price target raised by $4 at Oppenheimer, here's why

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…